author-photo

Jens Kuhle

University of Basel
University Hospital of Basel
Queen Mary University of London

334

Papers

10731

Citations

Citation Trend

Filter By

Papers (334) Sort By

Journal Conference Others

Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180].

2022 Computer Methods and Programs in Biomedicine
Show All
- Source
- Cite
- Save
Citations (0)
Early life serum neurofilament dynamics predict neurodevelopmental outcome of preterm infants.

2021 Journal of Neurology
Show All
- Source
- Cite
- Save
Citations (3)
Intrathecal Immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis.

2021 Annals of Neurology
Show All
- Source
- Cite
- Save
Citations (1)
Predictive value of serum neurofilament light chain for persistent cognitive deficits in elderly depressive patients

2021
Show All
- Source
- Cite
- Save
Citations (0)
Characteristics of improvements in balance control using vibro-tactile biofeedback of trunk sway for multiple sclerosis patients

2021 Journal of the Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (1)
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.

2021 Journal of Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (5)
CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event.

2021 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (1)
Mass Cytometry of CSF Identifies an MS-Associated B-cell Population.

2021 Neuroimmunology and Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (1)
Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML.

2021 Neuroimmunology and Neuroinflammation
Show All
- Source
- Cite
- Save
Citations (2)
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.

2021 Multiple Sclerosis Journal
Show All
- Source
- Cite
- Save
Citations (7)